Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Thanks TechGuru. I think many people have not

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154105
(Total Views: 1258)
Posted On: 04/19/2020 7:01:46 PM
Posted By: blafarm
Re: TechGuru #28516
Thanks TechGuru.

I think many people have not fully-captured, or processed, the importance of what was said during that part of the call.

I have been doing research on the global market size for both influenza and pneumonia for some time. So, I was quite excited when Dr. Patterson actually mentioned influenza by name -- because it represented the company's contemplation of that indication.

Video Link: https://youtu.be/pVhpq4kLDsE?t=2055
Quote:
"Yes, absolutely, there's other viral infections most notably influenza that happens every single year that also has a cytokine storm in its severe cases. So it's absolutely possible, and probable I would say, that we would be looking at leronlimab for influenza as well".

We've already discussed, in the most general of terms, what an influenza indication might be worth -- knowing full well that we don't have access to critically important metrics such as opportunity size, market penetration, peak annual sales, dose size/cost, and COGS.

However, I was a bit surprised that he didn't mention pneumonia, especially because it represents a market opportunity that is approximately ten times that of influenza. But in retrospect, I think he was just trying to present a garden variety example of a common viral infection, and leronlimab's applicability.

But then he said ...

Video Link: https://youtu.be/pVhpq4kLDsE?t=2096
Quote:
What we've learned through COVID is going to be incredibly beneficial for CytoDyn going forward in terms of ADDITIONAL indications (his emphasis -- not mine) and because of the broad effects that we see on the immune system.

Please use the video link above that quote and listen to the inflection of the word "ADDITIONAL". Quite frankly, the delivery of this quote floored me -- especially coming from someone like him, and how he has led the company to indications that no one else could possibly see.

Dr. Patterson is an extremely articulate man who chooses his words very carefully. I have yet to hear any evidence of exaggeration or hyperbole coming from his lips. And his very intentional emphasis of the word "ADDITIONAL" leads me to believe that a massive light bulb has gone off in his head. And this light bulb has probably been powered by the many weeks he and his team have been burning the midnight oil, obsessively studying the labs from the EIND patients, as well as preparing for the drafting and publishing of his research paper.

I certainly don't want to get ahead of myself, but I submit that if you were already impressed with the existing long laundry list of potential leronlimab indications -- you might want to prepare for that list to grow even longer. And it might grow to include some indications that we never considered, and that represent very significant annual revenue.


(14)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us